Literature DB >> 3841136

Hyperthyroidism due to Graves' disease and due to autonomous goiter.

H Schicha, D Emrich, I Schreivogel.   

Abstract

An attempt was made to classify 326 patients with hyperthyroidism due to Graves' disease and due to autonomous goiter in an area of endemic iodine deficient goiter using the following two sets of criteria: Primary criteria: the presence of endocrine ophthalmopathy (Graves' disease) and the absence of endocrine ophthalmopathy and the absence of microsomal antibodies greater than or equal to 1:1600 (autonomous goiter). Sixty-nine percent of the patients could be divided in the two groups with the aid of these criteria. Secondary criteria: age greater than 50 years, presence of a goiter, presence of thyroid nodules, activity distribution in the scan, iodine intake determined by iodine excretion in the urine. These criteria had to be applied in the 31% of the patients who could not be divided into one of the two groups using the primary criteria. The secondary criteria were accumulative. Using these criteria 55% of the 326 patients were classified as having Graves' disease and 45% as having autonomous goiter. The probability of correct grouping when both primary and secondary criteria were applied was estimated to be 90% compared to 54% when we used only the classical terms, i.e. endocrine ophthalmopathy and diffuse goiter on the one hand and multinodular goiter without endocrine ophthalmopathy on the other hand. In a second group of 120 hyperthyroid patients classified in this way, thyrotropin displacing activity was determined independently. Its prevalence was 79% in patients classified as having Graves' disease but only 3% in those classified as having autonomous goiter. The prevalence of TDA observed in patients who presumably had autonomous goiter was in the same range as in the following groups: 45 normal individuals; 126 patients with euthyroid goiter; and in 112 patients with euthyroid and hyperthyroid autonomous adenoma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3841136     DOI: 10.1007/bf03348523

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

1.  Autonomy in euthyroid goitre: maladaptation to iodine deficiency.

Authors:  D Emrich; M Bähre
Journal:  Clin Endocrinol (Oxf)       Date:  1978-03       Impact factor: 3.478

2.  [Risk of hyperthyroidism from iatrogenic iodine intake].

Authors:  C Schneider; G Stephan; M Suwelack
Journal:  Dtsch Med Wochenschr       Date:  1969-12-19       Impact factor: 0.628

3.  Autonomously functioning euthyroid multinodular goitre.

Authors:  J W Elte; A Haak; M Frölich; K S Wiarda; R K van Wermeskerken
Journal:  Neth J Med       Date:  1977       Impact factor: 1.422

4.  Serum thyrotropin concentrations under basal conditions and after stimulation with thyrotropin-releasing hormone in idiopathic non-toxic goiter.

Authors:  H Dige-Petersen; L Hummer
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

5.  [Decompensation of autonomous thyroid adenoma after long-term iodine intake (author's transl)].

Authors:  J Mahlstedt; K Joseph
Journal:  Dtsch Med Wochenschr       Date:  1973-09-21       Impact factor: 0.628

6.  TSH response pattern to TRH test and optimum time of blood sampling in sporadic euthyroid goitre.

Authors:  M Blichert-Toft; C Christiansen; C K Axelsson; J Egedorf
Journal:  Acta Med Scand       Date:  1978

7.  A receptor assay for the measurement of TSH receptor antibodies in unextracted serum.

Authors:  K Southgate; F Creagh; M Teece; C Kingswood; B Rees Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1984-05       Impact factor: 3.478

8.  Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves' disease.

Authors:  A M McGregor; M M Petersen; R Capiferri; D C Evered; B R Smith; R Hall
Journal:  Clin Endocrinol (Oxf)       Date:  1979-10       Impact factor: 3.478

9.  Effect of selective goitre resection on absent thyrotrophin response to thyrotrophin releasing hormone in idiopathic euthyroid goitres.

Authors:  M Blichert-Toft; C Christiansen; C K Axelsson; J Egedorf; H Ibsen; J Ibsen
Journal:  Clin Endocrinol (Oxf)       Date:  1978-02       Impact factor: 3.478

10.  Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?

Authors:  R S Brown; I M Jackson; S L Pohl; S Reichlin
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

View more
  2 in total

1.  The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients.

Authors:  D Reinwein; G Benker; M P König; A Pinchera; H Schatz; A Schleusener
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

2.  Noninflammatory Diffuse Follicular Hypertrophy/Hyperplasia of Graves Disease: Morphometric Evaluation in an Experimental Mouse Model.

Authors:  Anke Schlüter; Anja K Eckstein; Alexandra Brenzel; Mareike Horstmann; Stephan Lang; Utta Berchner-Pfannschmidt; J Paul Banga; Salvador Diaz-Cano
Journal:  Eur Thyroid J       Date:  2018-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.